Siirry sisältöön

Hups! Näyttää siltä ettemme löytäneet etsimääsi sivua

Virhekoodi: 404

Syynä voi olla mm. vanhentunut tai rikkinäinen linkki, tai järjestelmä sisäinen virhe.
Voit etsiä haluamaasi sivua ylävalikosta.

Biovian and 3P Biopharmaceuticals join forces to create 3PBIOVIAN

Biovian and 3P Biopharmaceuticals (“3P”), two leading biologics Contract Development and Manufacturing Organizations (CDMOs), announced today their combination to establish a new pan-European leader in their field. Backed by their common shareholder, Keensight Capital, one …

Biovian has been recognized as Turku Developer 2023

Junior Chamber International (JCI) Turku has recognized Biovian as the Turku Developer 2023. We are delighted and honored to announce that Biovian has received the Turku Developer 2023 award by JCI Turku, Finland on Friday, …

Biovian unveils the stonemasonry work of GeneCity facility

Biovian, a leading biopharmaceutical CDMO from Finland, uncovers the stonemasonry work of its new manufacturing facility, GeneCity. Located in a growing technology hub at Turku, Kupittaa, the state-of-the-art facility houses a blend of cutting-edge equipment …

Biovian’s growth story featured in Business Focus Magazine

We invite you to explore the recent article “Next Level Biopharmaceuticals” featured in the Business Focus Magazine’s latest issue. Business Focus Magazine interviewed Biovian’s CEO and co-founder Antti Nieminen about Biovian’s growth story and position …